top of page
poseidon-research-team-immunotherapy-lab.jpg

About

peptide-based-immunotherapy-research.jpg

Our goal is to provide treatments for solid tumors where other immunotherapies have fallen short – using high affinity and specific modalities without immune overactivation and cytokine response syndrome.

Poseidon is a privately held, pre-clinical biotechnology company bringing forward its modular Trident platform engineered to engage T cells specifically with cancer cells in the tumor microenvironment. 

Company Overview

Rajika Perera, PhD

raj hi res final.jpg

Co-Founder and CEO

Michael Longo, PhD, MD

michael headshot final psd final.jpg

Co-Founder and CSO

Meet The Team

Innovation led by a team with decades of experience in protein engineering.

John McCafferty, PhD

john final headshot.jpg

Scientific Advisor

Bud Bishop, MBA, PhD

bud final headshot 2.jpg

Business Advisor

Fadi Abu Shain, MD

fadi final headshot.jpg

Clinical Advisor

Firefly A single clean microscopic view background light blue gradient background, in the
t-cell-solid-tumor-engager.jpg
bottom of page